Describe the importance of early diagnosis and identify emerging intervention strategies in peripartum cardiomyopathy and pregnancy associated HF.

Speaker Objective(s):

Final Outcome Status for 1st North American Prospective IPAC Study of PPCM/PAC: Risk Profile for Recovery/Non-Recovery
Differential Diagnosis of Heart Failure in Pregnancy: Towards an Earlier Diagnosis/ Recognition
Role of Cardiac Magnetic Resonance (CMR) in PPCM/PAC
New Insights to Mechanisms of Peripartum Cardiomyopathy (with some time on new interventions such as bromocriptine)
Potential Newer Intervention Strategies in PPCM/PAC for Those at Highest Risk for Non-Recovery

Michael Givertz MD

Professor of Medicine, Brigham and Women's Hospital, Boston, MA